Predictors of mortality and disability in stroke-associated pneumonia

被引:0
|
作者
Rory J. Tinker
Craig J. Smith
Calvin Heal
Joao H. Bettencourt-Silva
Anthony K. Metcalf
John F. Potter
Phyo K. Myint
机构
[1] University of Manchester,Faculty of Biology, Medicine and Health
[2] Manchester Academic Health Science Centre,Greater Manchester Comprehensive Stroke Centre
[3] Salford Royal NHS Foundation Trust,Centre for Biostatistics
[4] University of Manchester,Room 4:013, Institute of Applied Health Sciences
[5] Manchester Academic Health Science Centre,Norwich Medical School
[6] School of Medicine,undefined
[7] Medical Sciences and Nutrition,undefined
[8] University of Aberdeen,undefined
[9] University of East Anglia,undefined
[10] Stroke Research Group,undefined
[11] Norwich Cardiovascular Research Group,undefined
[12] Norwich Research Park,undefined
[13] Stroke Services,undefined
[14] Norfolk and Norwich University Hospitals NHS Foundation Trust,undefined
来源
Acta Neurologica Belgica | 2021年 / 121卷
关键词
Stroke; Pneumonia; Mortailty; Morbidity; Stroke associated;
D O I
暂无
中图分类号
学科分类号
摘要
Whilst stroke-associated pneumonia (SAP) is common and associated with poor outcomes, less is known about the determinants of these adverse clinical outcomes in SAP. To identify the factors that influence mortality and morbidity in SAP. Data for patients with SAP (n = 854) were extracted from a regional Hospital Stroke Register in Norfolk, UK (2003–2015). SAP was defined as pneumonia occurring within 7 days of admission by the treating clinicians. Mutlivariable regression models were constructed to assess factors influencing survival and the level of disability at discharge using modified Rankin Scale [mRS]. Mean (SD) age was 83.0 (8.7) years and ischaemic stroke occurred in 727 (85.0%). Mortality was 19.0% at 30 days and 44.0% at 6 months. Stroke severity assessment using National Institutes of Health Stroke Scale was not recorded in the data set although Oxfordshire Community Stroke Project was Classification. In the multivariable analyses, 30-day mortality was independently associated with age (OR 1.04, 95% CI 1.01–1.07, p = 0.01), haemorrhagic stroke (2.27, 1.07–4.78, p = 0.03) and pre-stroke disability (mRS 4–5 v 0–1: 6.45, 3.12–13.35, p < 0.001). 6-month mortality was independently associated with age (< 0.001), pre-stroke disability (p < 0.001) and certain comorbidities, including the following: dementia (6.53, 4.73–9.03, p < 0.001), lung cancer (2.07, 1.14–3.77, p = 0.017) and previous transient ischemic attack (1.94, 1.12–3.36, p = 0.019). Disability defined by mRS at discharge was independently associated with age (1.10, 1.05–1.16, p < 0.001) and plasma C-reactive protein (1.02, 1.01–1.03, p = 0.012). We have identified non-modifiable determinants of poor prognosis in patients with SAP. Further studies are required to identify modifiable factors which may guide areas for intervention to improve the prognosis in SAP in these patients.
引用
收藏
页码:379 / 385
页数:6
相关论文
共 50 条
  • [1] Predictors of mortality and disability in stroke-associated pneumonia
    Tinker, Rory J.
    Smith, Craig J.
    Heal, Calvin
    Bettencourt-Silva, Joao H.
    Metcalf, Anthony K.
    Potter, John F.
    Myint, Phyo K.
    [J]. ACTA NEUROLOGICA BELGICA, 2021, 121 (02) : 379 - 385
  • [2] Predictors of mortality and disability in stroke associated pneumonia
    Tinker, R. J.
    Heal, C.
    Bettencourt-Silva, J. H.
    Metcalf, A. K.
    Bowles, K. M.
    Potter, J. F.
    Myint, P.
    Smith, C. J.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 50 - 50
  • [3] PREDICTORS OF STROKE-ASSOCIATED MORTALITY IN THE ELDERLY
    KHAW, KT
    BARRETTCONNOR, E
    SUAREZ, L
    CRIQUI, MH
    [J]. STROKE, 1984, 15 (02) : 244 - 248
  • [4] Novel Predictors of Stroke-Associated Pneumonia: A Single Center Analysis
    Li, Ya-Ming
    Zhao, Li
    Liu, Yue-Guang
    Lu, Yang
    Yao, Jing-Zhu
    Li, Chun-Ju
    Lu, Wei
    Xu, Jian-Hua
    [J]. FRONTIERS IN NEUROLOGY, 2022, 13
  • [5] Bacterial stroke-associated pneumonia: microbiological analysis and mortality outcome
    Aboulfotooh, Alshaimaa M.
    Aziz, Heba Sherif Abdel
    Zein, Marwa M.
    Sayed, Mohamed
    Ibrahim, Ahmed R. N.
    Abdelaty, Lamiaa N.
    Magdy, Rehab
    [J]. BMC NEUROLOGY, 2024, 24 (01)
  • [6] Impact of stroke-associated pneumonia on mortality, length of hospitalization, and functional outcome
    Teh, W. H.
    Smith, C. J.
    Barlas, R. S.
    Wood, A. D.
    Bettencourt-Silva, J. H.
    Clark, A. B.
    Metcalf, A. K.
    Bowles, K. M.
    Potter, J. F.
    Myint, P. K.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2018, 138 (04): : 293 - 300
  • [7] Stroke-Associated Pneumonia: Management Issues
    Verma, Rajesh
    [J]. JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2019, 10 (03) : 472 - 473
  • [8] Preventive antibiotics for stroke-associated pneumonia
    Andreas Meisel
    Craig J. Smith
    [J]. Nature Reviews Neurology, 2015, 11 : 672 - 673
  • [9] The multifactorial etiology of stroke-associated pneumonia
    Al-Khaled, Mohamed
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 400 : 30 - 31
  • [10] HYPOALBUMINEMIA PREDICTS STROKE-ASSOCIATED PNEUMONIA
    Yang, X.
    Wang, L.
    Zheng, L.
    Wang, D.
    Liu, M.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 457 - 457